Myelopathy as a Complication of Intrathecal Drug Infusion Systems

2007 ◽  
Vol 64 (2) ◽  
pp. 286 ◽  
Author(s):  
Stephen Knox ◽  
Richard P. Atkinson ◽  
Roger Stephens ◽  
Robert J. Coffey ◽  
Edie E. Zusman
2015 ◽  
pp. 1384-1408
Author(s):  
Filipe Quinaz ◽  
Paulo Fazendeiro ◽  
Miguel Castelo-Branco ◽  
Pedro Araújo

The automatic drug infusion in medical care environment remains an elusive goal due to the inherent specificities of the biological systems under control and to subtle shortcomings of the current models. The central aim of this chapter is to present an overview of soft computing techniques and systems that can be used to ameliorate those problems. The applications of control systems in modern medicine are discussed along with several enabling methodologies. The advantages and limitations of automatic drug infusion systems are analyzed. In order to comprehend the evolution of these systems and identify recent advances and research trends, a survey on the hypertension control problem is provided. For illustration, a state-of-the-art automatic drug infusion controller of Sodium Nitroprusside for the mean arterial pressure is described in detail. The chapter ends with final remarks on future research directions towards a fully automated drug infusion system.


2017 ◽  
Vol 20 (2) ◽  
pp. 96-132 ◽  
Author(s):  
Timothy R. Deer ◽  
Jason E. Pope ◽  
Salim M. Hayek ◽  
Anjum Bux ◽  
Eric Buchser ◽  
...  

Author(s):  
Filipe Quinaz ◽  
Paulo Fazendeiro ◽  
Miguel Castelo-Branco ◽  
Pedro Araújo

The automatic drug infusion in medical care environment remains an elusive goal due to the inherent specificities of the biological systems under control and to subtle shortcomings of the current models. The central aim of this chapter is to present an overview of soft computing techniques and systems that can be used to ameliorate those problems. The applications of control systems in modern medicine are discussed along with several enabling methodologies. The advantages and limitations of automatic drug infusion systems are analyzed. In order to comprehend the evolution of these systems and identify recent advances and research trends, a survey on the hypertension control problem is provided. For illustration, a state-of-the-art automatic drug infusion controller of Sodium Nitroprusside for the mean arterial pressure is described in detail. The chapter ends with final remarks on future research directions towards a fully automated drug infusion system.


2017 ◽  
Vol 124 (5) ◽  
pp. 1493-1505 ◽  
Author(s):  
Uoo R. Kim ◽  
Robert A. Peterfreund ◽  
Mark A. Lovich

2017 ◽  
Vol 2 (2) ◽  
Author(s):  
Mark A. Lovich ◽  
Robert A. Peterfreund

AbstractThis review aims to describe analytic models of drug infusion that demonstrate the impact of the infusion system common-volume on drug delivery. The common-volume of a drug infusion system is defined as the volume residing between the point where drug and inert carrier streams meet and the patient’s blood. We describe 3 sets of models. The first is quantitative modeling which includes algebraic mathematical constructs and forward-difference computational simulation. The second set of models is with in vitro benchtop simulation of clinical infusion system architecture. This modeling employs devices including pumps, manifolds, tubing and catheters used in patient care. The final set of models confirms in vitro findings with pharmacodynamic endpoints in living large mammals. Such modeling reveals subtle but important issues inherent in drug infusion therapy that can potentially lead to patient instability and morbidity. The common-volume is an often overlooked reservoir of drugs, especially when infusions flows are slowed or stopped. Even with medications and carriers flowing, some mass of drug always resides within this common-volume. This reservoir of drug can be inadvertently delivered into patients. When infusions are initiated, or when dose rate or carrier flow is altered, there can be a significant lag between intended and actual drug delivery. In the case of vasoactive and inotropic drug infusions, these unappreciated time delays between intended and actual drug delivery can lead to iatrogenic hemodynamic instability. When a drug infusion is discontinued, drug delivery continues until the common-volume is fully cleared of residual drug by the carrier. The findings from all 3 sets of models described in this review indicate that minimizing the common-volume of drug infusion systems may enhance patient safety. The presented models may also be configured into teaching tools and possibly point to technological solutions that might mitigate sources of iatrogenic patient lability.


2016 ◽  
Vol 124 (5) ◽  
pp. 1077-1085 ◽  
Author(s):  
Matthew J. Pezone ◽  
Robert A. Peterfreund ◽  
Mikhail Y. Maslov ◽  
Radhika R. Govindaswamy ◽  
Mark A. Lovich

Abstract Background The authors have previously shown that drug infusion systems with large common volumes exhibit long delays in reaching steady-state drug delivery and pharmacodynamic effects compared with smaller common-volume systems. The authors hypothesized that such delays can impede the pharmacologic restoration of hemodynamic stability. Methods The authors created a living swine simulator of hemodynamic instability in which occlusion balloons in the aorta and inferior vena cava (IVC) were used to manipulate blood pressure. Experienced intensive care unit nurses blinded to the use of small or large common-volume infusion systems were instructed to maintain mean arterial blood pressure between 70 and 90 mmHg using only sodium nitroprusside and norepinephrine infusions. Four conditions (IVC or aortic occlusions and small or large common volume) were tested 12 times in eight animals. Results After aortic occlusion, the time to restore mean arterial pressure to range (t1: 2.4 ± 1.4 vs. 5.0 ± 2.3 min, P = 0.003, average ± SD), time-out-of-range (tOR: 6.2 ± 3.5 vs. 9.5 ± 3.4 min, P = 0.028), and area-out-of-range (pressure–time integral: 84 ± 47 vs. 170 ± 100 mmHg·min, P = 0.018) were all lower with smaller common volumes. After IVC occlusion, t1 (3.7 ± 2.2 vs. 7.1 ± 2.6 min, P = 0.002), tOR (6.3 ± 3.5 vs. 11 ± 3.0 min, P = 0.007), and area-out-of-range (110 ± 93 vs. 270 ± 140 mmHg·min, P = 0.003) were all lower with smaller common volumes. Common-volume size did not impact the total amount infused of either drug. Conclusions Nurses did not respond as effectively to hemodynamic instability when drugs flowed through large common-volume infusion systems. These findings suggest that drug infusion system common volume may have clinical impact, should be minimized to the greatest extent possible, and warrants clinical investigations.


Sign in / Sign up

Export Citation Format

Share Document